Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography

British Journal of Cancer

Volumn 110, Issue 7, 2014, Pages 1727-1732

  Li, J ^a   Jamin, Y ^a   Boult, J K R ^a   Cummings, C ^a   Waterton, J C ^b   Ulloa, J ^b,d   Sinkus, R ^c   Bamber, J C ^a   Robinson, S P ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d Bioxydyn Limited   (United Kingdom)

Author keywords

magnetic resonance elastography; response biomarker; tumour viscoelasticity; vascular targeting agents

Indexed keywords

N ACETYLCOLCHINOL PHOSPHATE;

ANIMAL TISSUE; ARTICLE; CELL DEATH; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ELASTICITY; ELASTOGRAPHY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MAGNETIC RESONANCE ELASTOGRAPHY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SHEAR STRENGTH; SINGLE DRUG DOSE; TREATMENT RESPONSE; TUMOR XENOGRAFT; VISCOELASTICITY; VISCOSITY; YOUNG MODULUS;

ANGIOGENESIS INHIBITORS; ANIMALS; BIOMECHANICAL PHENOMENA; COLONIC NEOPLASMS; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; MICE; MICE, NUDE; NECROSIS; ORGANOPHOSPHORUS COMPOUNDS; SHEAR STRENGTH; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84897569887     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.76     Document Type: Article

References (31)

1. Baker LC, Boult JK, Walker-Samuel S, Chung YL, Jamin Y, Ashcroft M, Robinson SP (2012) The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function. Br J Cancer 106(10): 1638-1647.
2. Bamber J, Cosgrove D, Dietrich CF, Fromageau J, Bojunga J, Calliada F, Cantisani V, Correas JM, D'Onofrio M, Drakonaki EE, Fink M, Friedrich-Rust M, Gilja OH, Havre RF, Jenssen C, Klauser AS, Ohlinger R, Saftoiu A, Schaefer F, Sporea I, Piscaglia F (2013) EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography. Part 1: basic principles and technology. Ultraschall Med 34(2): 169-184.
3. Blakey DC, Ashton SE, Westwood FR, Walker M, Ryan AJ (2002a) ZD6126: a novel small molecule vascular targeting agent. Int J Radiat Oncol Biol Phys 54(5): 1497-1502.
4. Blakey DC, Westwood FR, Walker M, Hughes GD, Davis PD, Ashton SE, Ryan AJ (2002b) Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. Clin Cancer Res 8(6): 1974-1983.
5. Boult JK, Jamin Y, Jacobs V, Gilmour LD, Walker-Samuel S, Halliday J, Elvin P, Ryan AJ, Waterton JC, Robinson SP (2012) False-negative MRI biomarkers of tumour response to targeted cancer therapeutics. Br J Cancer 106(12): 1960-1966.
6. Cullis ER, Kalber TL, Ashton SE, Cartwright JE, Griffiths JR, Ryan AJ, Robinson SP (2006) Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the antitumour effects of the vascular disrupting agent ZD6126. Microvasc Res 71(2): 76-84.
7. Davis PD, Dougherty GJ, Blakey DC, Galbraith SM, Tozer GM, Holder AL, Naylor MA, Nolan J, Stratford MR, Chaplin DJ, Hill SA (2002) ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. Cancer Res 62(24): 7247-7253.
8. Dvorak HF, Weaver VM, Tlsty TD, Bergers G (2011) Tumor microenvironment and progression. J Surg Oncol 103(6): 468-474.
9. Garteiser P, Doblas S, Daire JL, Wagner M, Leitao H, Vilgrain V, Sinkus R, Van Beers BE (2012) MR elastography of liver tumours: value of viscoelastic properties for tumour characterisation. Eur Radiol 22(10): 2169-2177.
10. Heldin CH, Rubin K, Pietras K, Ostman A (2004) High interstitial fluid pressure-an obstacle in cancer therapy. Nat Rev Cancer 4(10): 806-813.
11. Horsman MR, Siemann DW (2006) Pathophysiologic effects of vasculartargeting agents and the implications for combination with conventional therapies. Cancer Res 66(24): 11520-11539.
12. Juge L, Doan BT, Seguin J, Albuquerque M, Larrat B, Mignet N, Chabot GG, Scherman D, Paradis V, Vilgrain V, Van Beers BE, Sinkus R (2012) Colon tumor growth and antivascular treatment in mice: complementary assessment with MR elastography and diffusion-weighted MR imaging. Radiology 264(2): 436-444.
13. Koh DM, Blackledge M, Collins DJ, Padhani AR,Wallace T, Wilton B, Taylor NJ, Stirling JJ, Sinha R, Walicke P, Leach MO, Judson I, Nathan P (2009) Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 19(11): 2728-2738.
14. Lorenzen J, Sinkus R, Lorenzen M, Dargatz M, Leussler C, Roschmann P, Adam G (2002) MR elastography of the breast:preliminary clinical results. Rofo 174(7): 830-834.
15. Michaelis LC, Ratain MJ (2006) Measuring response in a post-RECIST world: from black and white to shades of grey. Nat Rev Cancer 6(5): 409-414.
16. Muthupillai R, Ehman RL (1996) Magnetic resonance elastography. Nat Med 2(5): 601-603.
17. Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, Dzik-Jurasz A, Ross BD, Van Cauteren M, Collins D, Hammoud DA, Rustin GJ, Taouli B, Choyke PL (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11(2): 102-125.
18. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA, Weaver VM (2005) Tensional homeostasis and the malignant phenotype. Cancer Cell 8(3): 241-254.
19. Pepin KM, Chen J, Glaser KJ, Mariappan YK, Reuland B, Ziesmer S, Carter R, Ansell SM, Ehman RL, McGee KP (2013) MR elastography derived shear stiffness- A new imaging biomarker for the assessment of early tumor response to chemotherapy. Magn Reson Med; e-pub ahead of print 25 June 2013; doi:10.1002/mrm.24825.
20. Sahebjavaher RS, Baghani A, Honarvar M, Sinkus R, Salcudean SE (2013) Transperineal prostate MR elastography: initial in vivo results. Magn Reson Med 69(2): 411-420.
21. Siegmann KC, Xydeas T, Sinkus R, Kraemer B, Vogel U, Claussen CD (2010) Diagnostic value of MR elastography in addition to contrast-enhanced MR imaging of the breast-initial clinical results. Eur Radiol 20(2): 318-325.
22. Sinkus R, Lorenzen J, Schrader D, Lorenzen M, Dargatz M, Holz D (2000) High-resolution tensor MR elastography for breast tumour detection. Phys Med Biol 45(6): 1649-1664.
23. Sinkus R, Siegmann K, Xydeas T, Tanter M, Claussen C, Fink M (2007) MR elastography of breast lesions: understanding the solid/liquid duality can improve the specificity of contrast-enhanced MR mammography. Magn Reson Med 58(6): 1135-1144.
24. Sinkus R, Van Beers BE, Vilgrain V, DeSouza N, Waterton JC (2012) Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development. Eur J Cancer 48(4): 425-431.
25. Tozer GM, Kanthou C, Baguley BC (2005) Disrupting tumour blood vessels. Nat Rev Cancer 5(6): 423-435.
26. Vogel-Claussen J, Gimi B, Artemov D, Bhujwalla ZM (2007) Diffusionweighted and macromolecular contrast enhanced MRI of tumor response to antivascular therapy with ZD6126. Cancer Biol Ther 6(9): 1469-1475.
27. Walker-Samuel S, Orton M, Boult JK, Robinson SP (2011) Improving apparent diffusion coefficient estimates and elucidating tumor heterogeneity using Bayesian adaptive smoothing. Magn Reson Med 65(2): 438-447.
28. Waterton JC (2013) Translational magnetic resonance imaging and spectroscopy: opportunities and challenges. In: New Applications of NMR in Drug Discovery and Development, Chapter 12, pp 333-360. The Royal Society of Chemistry: Cambridge, UK.
29. Waterton JC, Pylkkanen L (2012) Qualification of imaging biomarkers for oncology drug development. Eur J Cancer 48(4): 409-415.
30. Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DA, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102(11): 1555-1577.
31. Yeung DK, Bhatia KS, Lee YY, King AD, Garteiser P, Sinkus R, Ahuja AT (2013) MR elastography of the head and neck: driver design and initial results. Magn Reson Imaging 31(4): 624-629.